Aarti Pharmalabs
AARTIPHARM INCompletedINMakes drug ingredients (APIs) and intermediates, caffeine and related compounds, and does contract manufacturing for drug companies, from plants in Gujarat and Maharashtra, India.
Aarti Industries demerged its pharmaceuticals business into Aarti Pharmalabs, issuing one Aarti Pharmalabs share for every four Aarti Industries shares (record date 20 October 2022), with the new company listing on NSE and BSE.
- Distribution date
- 30 Jan 2023
- Structure
- Spin-off
- Parent
- Aarti Industries (AARTIIND IN)
- Spin-off ticker
- AARTIPHARM IN
- Listing
- NSE and BSE
- Market
- India
- Sector
- Health care
- Size
- small
Source documents
- Press releaseNot located
- PresentationNot located
- Prospectus / demerger documentNot located
- Sourcebusiness-standard.com
Every Spin-Off research
No report on this situation yet. New reports are published on Substack first.
Receive reports by email